Six decades of vaccine development - A personal history

Nature Medicine

Volumn 4, Issue 5 SUPPL., 1998, Pages 507-513

  Hilleman, Maurice R ^a,b  

^a Merck Institute for Therapeutic Research   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ANIMAL; ANIMAL DISEASE; ART; ARTICLE; FORECASTING; HISTORY; HUMAN; LITERATURE; UNITED STATES; VACCINATION;

ANIMALS; AUTOBIOGRAPHY; FORECASTING; HISTORY, 20TH CENTURY; HUMANS; PORTRAITS; UNITED STATES; VACCINATION; VACCINES;

EID: 0032067663     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598supp-507     Document Type: Article

References (150)

1. Plotkin, M.S.L.S. & Plotki n, S.A. Vaccines, (eds. Plotkin S.A. & Mortimer, E.A.) Ch. 1,1-7 (W.B. Saunders, Philadelphia, 1988).
2. Jenner, E. An Inquiry into the Causes and Effects of the Variolae Vacdnae (Low, London, 1798).
3. Enders, J.F., Weller, T.H. & Robbins, F.C. Science 109, 85-87 (1949).
4. Austrian, R. Rev. Infect. Dis. 3, 183-189 (1981).
5. Hilleman, M.R. I. Inf. Dis. 76, 96-114 (1945).
6. Sabin, A.B. J. Amer. Med. Assoc. 122, 478-486 (1943).
7. Hilleman, M.R. & Nigg, C. J. Immunol. 53, 201-208 (1946).
8. Hilleman, M.R. & Nigg, C. J. Immunol. 59, 349-364 (1948).
9. Hilleman, M.R., Buescher, E.L. & Smadel, J. E. Pub. Hith. Repts. 66,1195-1203 (1951).
10. Hilleman, M.R., Mason, R.P. & Rogers, N.G. Pub. Hlth. Repts. 65, 771-777 (1950).
11. Hilleman, M.R., Mason, R.P. & Buescher, E.L. Proc. Soc. Exper. Biol. Med. 75, 829-835 (1950).
12. Hilleman, M.R. & Horsfall, F.L. J. Immunol. 69, 343-356 (1952).
13. Hilleman, M.R. Ann. Rev. Microbiol. 8, 3111-332 (1954).
14. Hilleman, M.R., Werner, J.H. & Cauld, R. L. Bull. WHO 8, 613-631 (1953).
15. Webster, R.C. Encyclopedia of Virology, (eds. Webster, R.C. & Granoff, A.) Vol. 2, 709-727 (Academic Press, New York, 1994).
16. Meyer, H.M., Jr., Hilleman, M.R., Miesse, M.L., Crawford, I. P. & Bankhead, A.S. Proc. Soc. Cxper. Biol. Med. 95, 609-616 (1957).
17. Hilleman, M.R. Military Med. 123, 23-30 (1958).
18. Hilleman, M. R., Flatley, F.|., Anderson, S.A., Luecking, M.L. & Levinson, D.J. J. Amer. Med. Assoc. 166,1134-1140 (1958).
19. Hilleman, M.R., Werner, J. H., Adair, C.V. & Dreisbach, A. R. Am. J. Hygiene 61, 163-173(1955).
20. Hilleman, M.R. & Werner, J.H. Proc. Soc. Exper. Biol. Med. 85,183-188 (1954).
21. Hilleman, M.R., Werner, J.H., Dascomb, H. E. & Butler, R.L. Am. J. PubJ. Hlth. 45,203-210(1955).
22. Dascomb, H.E. & Hilleman, M.R. Am. J. Med. 21,161-174 (1956).
23. Hilleman, M.R., Werner, J.H., Dascomb, H.E., Butler, R.L. & Stewart, M.T. Am. I. Hygiene 62. 29-43 (1955).
24. Hilleman, M.R., Tousimis, A.J. & Werner, J.H. Proc. 5oc. Cxper. Biol. Med. 89, 587-593(1955).
25. Tousimis, A.J., & Hilleman, M.R. Virology 4, 499-508 (1957).
26. Hilleman, M.R., Werner, J.H. & Stewart, M.T. Proc. Soc. Exper. Biol. Med. 90, 555-562(1955).
27. Rowe, W.P., Huebner, R.)., Cilmore, L.K., Parrott, R.H. & Ward, T.G. Proc. Soc. Exper. Biol. Med. 84, 570-573 (1953).
28. Enders, J.F. et al. Science 124,119-120 (1956).
29. Hilleman, M.R., Stallones, R.A., Gauld, R.L., Warfield, M. S. & Anderson, S.A. Proc. Soc. Cxper. Biol. Med. 92, 377-383 (1956).
30. Hilleman, M.R., Warfield, M. S., Anderson, S.A. & Werner, J.H. J. Amer. Med. Assoc. 163, 4-9(1957).
31. Stallones, R.A., Hilleman, M.R., Gauld, R.L, Warfield, M.S. & Anderson, S.A. J. Amer. Med. Assoc. 163, 9-15 (1957).
32. Hilleman, M R., Greenberg, J. H., Warfield, M.S., Anderson, S.A. & Glabere, R.R. A.M.A. Arch. Int. Med. 102, 428-436 (1958).
33. Robbins, F.C. Vaccines, (eds. Plotkin, S.A. & Mortimer, E.A., Jr.) Ch. 6, 98-114 (Publisher, City, 1988).
34. Enders, J.F., Katz, S.L. & Holloway, A. New Cngl. J. Med. 263,153-159 (1960).
35. Katz, S.L., Enders, J.F. & Holloway, A. New Engl. J. Med. 263,159-161 (1960).
36. Reilly, C.M., Stokes, J., Jr., Buynak, E.B., Goldner, H. & Hilleman, M.R. New Engl. I. Med. 265,165-169 (1961).
37. Stokes, J. et al. New Engl. J. Med. 265, 507-513 (1961).
38. Stokes, J., Jr., Weibel, R., Halenda, R., Reilly, C.M. & Hilleman, M.R. Am. J. Publ. Hlth. 52, 29-43 (1962).
39. Hilleman, M.R. et al. Am. J. Publ. Hlth. 52,44-56 (1962).
40. Hughes, W.F., Watanabe, D.H. & Rubin, H. Avion Dis. 7,154-165 (1963).
41. Hilleman, M.R. et al. J. Amer. Med. Assoc. 206, 587-590 (1968)
42. Buynak, E.B. & Hilleman, M.R. Proc. Soc. Cxper. Biol. Med. 123, 768-775 (1966).
43. Stokes, J., Jr., Weibel, R.E., Buynak, EB., Whitman, J.E., Jr., & Hilleman, M.R. Pediatrics 39, 363-371 (1967).
44. Weibel, R.E., Stokes, J. Jr., Buynak, E.B., Whitman, J.E., Jr., & Hilleman, M.R. N. Engl. J. Med. 276, 245-251 (1967).
45. Hilleman, M.R., Weibel, R.E., Buynak, E. B., Stokes, Jr. Jr., & Whitman, J.E. N. Engl. I. Med. 276, 252-258 (1967.)
46. Weller, T.H. & Neva, F.A. Proc. Soc. Cxper. Biol. Med. 111,215-225 (1962).
47. Parkman, P.D., Buescher, E.L. & Artenstein, M.S. Proc. Soc. Exper. Biol. Med. 111,225-230(1962).
48. Buynak, E.B., Larson, V.M., McAleer, W.J., Mascoli, C.C., & Hilleman, M.R. Amer. I. Dis. Child. 118, 347-354(1969).
49. Weibel, R.E. étal. J. Amer. Med. Assoc. 205, 554-558 (1968)
50. Buynak, E.B., Hilleman, M.R., Weibel, R.E., & Stokes, Jr., J. J. Amer. Med. Assoc. 204, 195-200 (1968)
51. Hilleman, M.R., Buynak, E.B., Weibel, R.E. & Stokes, Jr. J. N. Engl. J. Med. 279, 300-303(1968)
52. Stokes, Jr. J., Weibel, R.E., Buynak, E.B., & Hilleman, M.R. Symp. Series Immunobiol. Standard. 11, 415-422 (Karger, Basel/New York, 1969).
53. Stokes, Jr.)., Weibel, R.E., Buynak, E.B. & Hilleman, M.R. Pediatrics. 44, 217-224 (1969).
54. Weibel, R.E., Stokes, J.Jr., Buynak, E.B., & Hilleman, M.R. Amer. J. Dis. Child. 118, 226-229 (1969).
55. Hilleman, M.R., Buynak, E.B., Whitman, J.E. Jr., Weibel, R.E., & Stokes, J.Jr. Amer. J. Dis. Child. 118,166-171 (1969).
56. Weibel, R.E., Stokes, J. Jr., Buynak, E.B., Hilleman, M.R., & Grunmeier, P.W. Pediatrics 37, 913-920 (1966).
57. Kabbus, F., Sansarricq, H., Lambin, P., Proulx, J., St Hilleman, M.R. Am J. Epidem. 86, 93-111 (1967).
58. Hilleman, M.R. Vaccinia, Vaccination and Vaccinology: tenner, Pasteur and their successors, (eds. Plotkin, S. 6t Fantini, B.) 283-292 (Elsevier, Paris, 1996).
59. Hilleman, M.R. Combination Vaccines, (ed. Ellis, R.W.) (Humana Press, Totowa, NJ,) in press.
60. Hatziandreu, E.J., Brown, R.F. & Halpern, M.T. Report to the Centers for Disease Coantrol and Prevention. Cost benefit analysis of the measlesmumps-rubella (MMR) vaccine. (Battelle, Arlington, VA, May 14,1994).
61. Neff, B.J. et al. Proc. Soc. Exper. Biol. Med. 166, 339-347 (1981).
62. Takahashi, M., Asano, Y., Kamiya, H. & Baba, K. Microbiol. Sciences 2, 249-254(1985).
63. Weibel, R.E. étal. N. Engl. J. Med. 310,1409-1415 (1984).
64. Okazaki, W., Purchase, H.C. & Burmester, B.R. Avion Dis. 14, 413-429,1970.
65. Hilleman, M.R. Avion Dis. 16,191-199 (1972).
66. Hilleman, M.R. Viruses, [volution, and Cancer. Basic Considerations, (eds. Kurstak, E. & Maramorosch, K.) 549-560 (Academic Press, New York, 1974).
67. Salk, J. & Drucker, J. Vaccines, (eds. Plotkin, S.A. 61 Mortimer, E.A.) Ch. 8, 158-181 (W.B. Saunders, Philadelphia, 1988).
68. Melnick, J.L. Vaccines, (eds. Plotkin, S.A. & Mortimer, E.A.) Ch. 7, 115-157 (W.B. Saunders, Philadelphia, 1988).
69. Hilleman, M.R. et al. Acad. Med. N. j. Special Bull., 6 (3), 1-31 (1960).
70. Charney, J, Tytell, A A., Machlowitz, R.A. & Hilleman, M.R. J. Amer. Med. Assoc. 177,591-595(1961).
71. Hull, R.N.Virology Monographs, (eds. Card, S., Hallauer, C, & Meyer, K.F.) 2-66 (Springer-Verlag, New York, 1968).
72. Sweet, B.H. & Hilleman, M.R. Second International Conference on Live Poliovirus Vaccines, Pan American Health Organization and the W.H.O., Washington, DC, 6-7 June, 1960, pp 79-85.
73. Sweet, B.H. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 105, 420-427 (1960).
74. Hilleman, M.R. Dev. Biol. Stand. (1998), in press.
75. Cirardi, A.J., Sweet, B.H., Slotnick, V.B. & Hilleman, M.R. Proc. Soc. Exper Biol Med 109, 649-660 (1962).
76. Cirardi, A.J., Sweet, B.H., & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 112, 662-667(1963).
77. Goldner, H., Girardi, A.J., Larson, V.M., &t Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 117, 851-857(1964).
78. Levine, A. Adv. Cancer Res. 65,141-148 (1994).
79. Butel, J.S. Encyclopedia of Virology, (eds. Webster, R.G. & Granoff, A.) 3, 1322-1329 (Harcourt Brace & Co., New York, 1994).
80. Hilleman, M.R. et al. Amer. J. Med. Sci. 270,401-404 (1975).
81. Buynak, E.B. et al. J. Amer. Med. Assoc. 235, 2832-2834 (1976).
82. Hilleman, M.R. et al. Viral Hepatitis, (eds. Vyas, G.N., Cohen, S.N. & Schmid, R.) 525-537 (Franklin Institute Press, Philadelphia, 1978).
83. Hilleman, M.R., Buynak, E.B., McAleer, W.J., McLean A.A., & Tytell, A.A. Virus and the Liver, (eds. Bianchi, L., Gerok, W., Sickinger, K. & Stalder, G.A.) 389-395 (MTP Press Ltd., London., 1979).
84. Hilleman, M.R. et al. Viral Hepatitis. 1981 International Symposium, (eds. Szmuness, W., Alter, H. & J. Maynard, J.) 385-397 (The Franklin Institute Press Philadelphia, 1982).
85. Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.)., & Kellner, A. A. Hepatology 1, 377-385 (1981).
86. Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G. & Hall, B.D. Nature 298, 347-350(1982).
87. McAleer, W.J. et al. Nature 307,178-180 (1984).
88. Hilleman, M.R. Infection 15, 2-6 (1987).
89. Hilleman, M.R., Weibel, R.E. & Scolnick, E.M. J. Hong Kong Med. Assoc. 37, 75-85(1985).
90. Hilleman, M.R. Advances in Exper. Med. & Biol. series (eds. Petricciani, J.C., Hopps, H.E. & Chappie, P.J.) 47-58 (Plenum Publishing, New York, 1979).
91. McAleer, W.J. et al. J. Virol. Meth. 7, 263-271 (l 983).
92. McAleer, W.J. et al. Proc. Soc. Exper. Biol. Med. 175, 314-319 (1984).
93. Hilleman, M.R. et al. Viral Hepatitis and Liver Disease, (eds. Vyas, G.N., Dienstag, J. & Hoofnagle, J.) 307-314 (Grune & Stratton, Orlando, Florida, 1984).
94. Hilleman, M.R. J. Med. Virol. 31, 5-12 (1990).
95. Hilleman, M.R. Hepatitis B Vaccines in Clinical Practice, (ed. Ellis, R.W.) Ch. 2, 17-39 (Marcel Dekker, New York, 1979).
96. Hilleman, M.R. Microbe Hunters, Then and Now. (eds. Koprowski, H. & Oldstone, M.B.A.) Ch. 16, 221-233 (Medi-Ed Press, Bloomington, IL, 1996).
97. Hilleman, M.R. Vaccinia, Vaccination and Vaccinology: lenner, Pasteur and their successors. (eds.Plotkin, S. & Fantini, B.) 199-209 (Eisevier, Paris, 1996).
98. Mascoli, C.C. et al. Proc. Soc. Exper. Biol. Med. 142, 276-282 (1973).
99. Provost, P.J., Ittensohn, O.L., Villarejos, V.M., Arguedas G., J.A. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 142, 1257-1267 (1973).
100. Deinhardt, F., Holmes, A.W., Capps, R.B.. & Popper, H. J. Exper. Med. 125, 673-678(1967).
101. Simons, J.N. et al. Proc. Natl. Acad. Sci. USA. 92, 3401-3405 (1995).
102. Hilleman, M.R. et al. Dev. Biol. Stand. 30, 383-389 (1975).
103. HiIleman, M.R. et al. Dev. Biol. Stand. 30, 418-424 (1975).
104. Provost, P.). et al. Proc. Soc. Exper. Biol. Med. 148, 532-539 (1975).
105. Provost, P.). et al. Amer. j. Med. Sci. 270, 87-92 (1975).
106. Provost, P. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 159, 201-203 (1978).
107. Provost, P.). £t Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 160, 213-221 (1979).
108. Provost, P.|. et al. Proc. Soc. Exper. Biol. Med. 170, 8-14 (1982).
109. Provost, P.). et al. I. Med. Virol. 20,165-175 (1986).
110. Midthun, K. et al. J Infect Dis 163, 735-739 (1991).
111. Midthun, K. et al. J Infect Dis 327, 453-457 (1992)..
112. Provost, P.). et al. Med. Virol. 19, 23-31 (1986).
113. Lewis, I.A. et al. Viral Hepatitis and Liver Disease, (eds. Hollinger, F.B., Lemon, S.M. & Margolis, H.) 94-97 (Williams & Wilkins, Baltimore, 1991).
114. Werzberger, A. et al. N. Engl. J Med. 327, 453-457 (1992).
115. Hilleman, M.R. J. Hepatology 18, S5-S10 (1993).
116. Hilleman, M.R. Proceedings of the Symposium on Highlights of Viral Hepatitis and Hepatocellular Carcinoma Research, 1992 (eds. Oon, C-J. & Aw, S-E.) 86-95 (Harper Press (Pte) Ltd, Singapore, 1993).
117. Hilleman, M.R. et al.J. Castroenterol. Hepatol. 8, S21-S26 (1993). llS.Cotschlich, E.C., Liu, T.Y. & Artenstein, M.S. J. Exper. Med. 129, 1349-1365 (1969).
118. Weibel, R.E. et al. Proc. Soc. Exper. biol. Med. 153,436-440 (1976).
119. Lepow, M.L. Vaccines. 2nd Ed. (eds. Plotkin S.A. & Mortimer, E.A. Jr.) Ch. 17, 503-515 (W.B. Saunders, Philadelphia, 1994).
120. Fedson, D.S. Vaccines, (eds. Plotkin S.A. & Mortimer, E.A.) Ch. 13, 271-299 (W.B. Saunders, Philadelphia, 1988).
121. Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H.J. & Hilleman, M.R.J. Amer. Med. Assoc. 238, 2613-2616 (1977).
122. Austrian, R. et al. Trans. Assoc. Amer. Physicians. 89,184-189 (1976).
123. Hilleman, M.R. Bull. WHO 55 (S2), 31-33 (1977).
124. Hilleman, M.R., McLean, A.A., Vella, P.P., Weibel, R.E. & Woodhour, A.F. Bull. WHO 56, 371-375(1978).
125. Hilleman, M.R., McLean, A.A., Vella, P.P., Weibel, R.E. & Woodhour, A.F. J. Infection 1,1-16 (1979).
126. Hilleman, M.R. et al. Pneumonia and Pneumococcal Infections, (eds. Lambert, H.P. & Caldwell, A.D.S.) Royal Soc. Med. Intl. Congr. & Symp. Series 27, 67-85 (Academic Press, London, 1980).
127. Hilleman, M.R. et al. Rev. Infect. Dis. 3, 531-542(1981).
128. Tai, J.Y. et al. Proc. Soc. Exper. Biol. Med. 184,154-161 (1987).
129. Santosham, M. Wolff, M., Reid, R, et al. N. Engl. J. Med. 324, 1767-1772 (1991).
130. Hilleman, M.R. et al. J. Amer. Med. Assoc. 180, 445-453 (1962)..
131. Hilleman, M. R. Am. Rev. Resp. Dis. 87,165-180 (1963).
132. Woodhour, A.F. et al. Am. Rev. Resp. Dis. 94, 350-361 (1966).
133. Weibel, R.E., Stokes, J. Jr., Leagus, M.B., Mascoli, C.C. & Hilleman, M.R. Am. Rev. Resp. Dis. 94, 362-379 (1966).
134. Leagus, M.B., Weibel, R.E., Mascoli, C.C., Stokes, J. Jr. & Hilleman, M.R. Am. Rev. Resp. Dis., 95, 838-844 (1967).
135. Hilleman, M.R. et al. PAHO Sci. PubJ. 147,141-154 (Nov., 1966).
136. Weibel, R.E. et al. Am. Rev. Resp. Dis. 96, 724-739 (1967). 1 SS.Vella, P.P. et al. Am. Rev. Resp. Dis. 99, 526-541 (1969).
137. Buynak, E.B., Weibel, R.E., McLean, A.A. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 157, 636-642 (1978).
138. Hilleman, M.R. Ergebnisse der Mikrobiologie Immunitatsforschun und Experimentellen Therapie, Springer-Verlag, Heidelberg, 41,1-22 (1967).
139. Pelon, W. Amer J. Hygiene. 73, 36-54 (1961).
140. Tyrrell, D.A.J. & Bynoe, M.L. Brit. Med. f. 5223, 393-397 (1961).
141. Hamparian, V.V., Keller, A. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 103, 444-453 (1961).
142. Ketler, A., Hamparian, V.V. & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 110, 821-831 (1962).
143. Hamparian, V.V., Keller, A. & Hilleman, M.R. Am. Rev. Resp. Dis. 88, 269-273 (1963).
144. Hamparian, V.V., Leagus, M.B., & Hilleman, M.R. Proc. Soc. Exper. Biol. Med. 116, 976-984 (1964).
145. Mascoli, C.C., Leagus, M.B., Hilleman, M.R., Weibel, R.E., & Stokes, J. Jr. Proc. Soc. Exper. Biol. Med. 124, 845-850 (1967).
146. Tyrrell, D.A.J. & Chanock, R.M. Science 141,152-153 (1963).
147. Hamparian, V.V., Leagus, M.B., & Hilleman, M.R., Stokes, J., Jr. Proc. Soc. Exper. Biol. Med. 117, 469-476 (1964).
148. Mascoli, C.C. et al. Proc. Soc. Exper. Biol. Med. 121,1264-1268 (1966).
149. 151.The World Health Reporl 1996, World Heallh Organization, Geneva, 137 pages (1996).
150. The CVI Slralegic Plan. Managing Opportunity and Change: A Vision of Vaccination for the 21st Cenlury. Children's Vaccine Initiative, W.H.O., Geneva (1997).